Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
20,250,000
-
Total 13F shares
-
5,079,935
-
Share change
-
+1,439,554
-
Total reported value
-
$20,269,051
-
Put/Call ratio
-
0%
-
Price per share
-
$3.99
-
Number of holders
-
36
-
Value change
-
+$6,075,451
-
Number of buys
-
19
-
Number of sells
-
11
Institutional Holders of enVVeno Medical Corp - Common Stock, $0.00001 par value per share (NVNO) as of Q2 2025
As of 30 Jun 2025,
enVVeno Medical Corp - Common Stock, $0.00001 par value per share (NVNO) was held by
36 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,079,935 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, KINGDON CAPITAL MANAGEMENT, L.L.C., VANGUARD GROUP INC, Nantahala Capital Management, LLC, Westside Investment Management, Inc., OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC), Universal- Beteiligungs- und Servicegesellschaft mbH, GEODE CAPITAL MANAGEMENT, LLC, JPMORGAN CHASE & CO, and MORGAN STANLEY.
This page lists
37
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.